Intradiscal Stem Cell Treatment for Failed Back Surgery

Intradiscal Stem Cell Treatment for Failed Back Surgery

Millions of Americans suffer from lower back pain. The spine is a complex structure with a complex mechanism, and a failure in any component can cause debilitating pain and poor quality of life.

Some people undergo surgeries, such as spinal fusion, to relieve back pain. However, spine surgeries carry their own risks, like nerve damage, infections, and other side effects. In some cases, the spinal surgery just won’t work. Some patients may even have multiple surgeries and yet experience pain. Failed back surgery syndrome (FBSS) is a real issue for many patients.

Causes of FBSS

Several risk factors can result in a poor outcome after a back surgery –

  • Smoking, which negatively affects blood circulation
  • Scar tissue formation
  • Persistent problems due to arthritis
  • Nerve damage
  • Pressure from narrowing of the spinal canal

Intradiscal Stem Cell Treatment

Intradiscal stem cell treatment is an effective pain relief option for failed back surgery patients who or patients,who are looking for a non-surgical treatment option.

Patients, who suffer from chronic disc or facet joint issues, and patients with specific acute injuries, such as whiplash, are ideal candidates for intradiscal stem cell treatments.

Conditions where Intradiscal Stem Cell Treatment may help

Here are two chronic back pain conditions whose patients may benefit from stem cell treatment.

·       Degenerative Disc Disease

As people age, the intervertebral discs start degenerating. Since these discs help you bend and twist, any damage to them can cause severe pain.Stem cell treatment can alleviate pain in these patients without an invasive surgery.

·       Facet Joint Disease

Facet joints stabilize the discs and the body of the spine. These joints are covered with cartilage to help in movement.When this cartilage becomes damaged, it can cause joint rubbing and back pain. Stem cell treatment can help in relieving pain due to this issue.

No Comments

Sorry, the comment form is closed at this time.